Selective VPAC2 receptor peptide agonists

Details Selective VPAC2 receptor peptide agonists Selective VPAC2 receptor peptide agonists

2011-03-01

2011-03-01

Bradley, Christina (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

07897573

ABSTRACT:
The present invention encompasses peptides that selectively activate the VPAC2 receptor and are useful in the treatment of diabetes.

REFERENCES:
patent: 6242563 (2001-06-01), Dong
patent: 2004/0058870 (2004-03-01), Froland et al.
patent: 0 450 100 (1991-10-01), None
patent: 06 092991 (1994-04-01), None
patent: WO 98/02453 (1998-01-01), None
patent: WO 00/05260 (2000-02-01), None
patent: WO 00/66629 (2000-11-01), None
patent: WO 01/23420 (2001-04-01), None
patent: WO 03/058203 (2003-07-01), None
patent: WO 03/099314 (2003-12-01), None
patent: WO 2004/006839 (2004-01-01), None
patent: WO 2005/058954 (2005-06-01), None
patent: WO 2005/072385 (2005-08-01), None
patent: WO 2006/023356 (2006-03-01), None
patent: WO 2006/023358 (2006-03-01), None
patent: WO 2006/042152 (2006-04-01), None
patent: WO 2007/044591 (2007-04-01), None
patent: WO 2008/043102 (2008-04-01), None
International Search Report of corresponding International Application No. PCT/US2006/041550, dated Feb. 15, 2007.

Affiliated with

Also associated with

Rating

Selective VPAC2 receptor peptide agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Selective VPAC2 receptor peptide agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective VPAC2 receptor peptide agonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2763293